Jenburkt Pharmaceuticals | JENBURKT | NSE - Pharmaceuticals
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..
Upgrade Membership to see 10 year accurate financial statements.
Chart | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Cash and cash equiva... |
| 421 | 411 | 517 | 577 | 565 |
Short-term investment |
| 0 | 38 | 35 | 16 | 3 |
Accounts receivables |
| 91 | 125 | 229 | 178 | 140 |
Inventories |
| 107 | 68 | 98 | 109 | 76 |
Deferred income taxes |
| 0 | 0 | 0 | 0 | 0 |
Other current assets |
| 19 | 17 | 17 | 16 | 16 |
Total current assets |
| 638 | 659 | 897 | 895 | 799 |
Gross property plant... |
| 105 | 94 | 94 | 89 | 85 |
Accumulated Depriciat... |
| 0 | 0 | 0 | 0 | 0 |
Net property, plant and Eq... |
| 105 | 94 | 94 | 89 | 85 |
Work in Progress |
| 0 | 0 | 10 | 1 | 4 |
Miscellaneous Investment |
| 12 | 17 | 20 | 26 | 294 |
Deferred income taxes |
| 0 | 0 | 4 | 0 | 0 |
Intangible assets |
| 1 | 1 | 2 | 8 | 5 |
Goodwill |
| 0 | 0.01 | 0.01 | 0.01 | 0.01 |
Other long-term assets |
| 0 | 3 | 2 | 23 | 17 |
Total non-current assets |
| 118 | 115 | 132 | 148 | 405 |
Total assets |
| 756 | 775 | 1,028 | 1,043 | 1,204 |
Short-term debt |
| 61 | 0.05 | 75 | 34 | 37 |
Accounts Payable... |
| 60 | 41 | 65 | 52 | 36 |
Provisions |
| 3 | 2 | 4 | 22 | 13 |
Taxes Payable |
| 0 | 0.86 | 1 | 4 | 1 |
Deferred Revenues |
| 0 | 0 | 0 | 0 | 0 |
Capital Leases |
| 0 | 0 | 0 | 0 | 4 |
Other current liabilities |
| 54 | 87 | 80 | 85 | 88 |
Total current liabilities |
| 179 | 131 | 226 | 198 | 179 |
Long-term debt |
| 2 | 2 | 0 | 0 | 0 |
Investments Liabilities |
| 0 | 0 | 0 | 0 | 0 |
Deferred tax liabilities |
| 5 | 1 | 0 | 2 | 0.83 |
Provisions |
| 4 | 0 | 0 | 0 | 0 |
Capital Leases |
| 0 | 0 | 0 | 0 | 9 |
Other longterm liabilities |
| 29 | 28 | 27 | 43 | 30 |
Total non-current liabilities |
| 40 | 31 | 27 | 45 | 40 |
Total liabilities |
| 220 | 162 | 254 | 243 | 219 |
Share Capital |
| 46 | 46 | 46 | 46 | 46 |
Share premium |
| 0 | 0 | 0 | 0 | 0 |
Retained earnings |
| 490 | 567 | 729 | 754 | 939 |
Accumulated other equity |
| 0 | 0 | 0 | 0 | 0 |
Preferred Stock |
| 0 | 0 | 0 | 0 | 0 |
Minority Interest |
| 0 | 0 | 0 | 0 | 0 |
Total Equity |
| 537 | 613 | 775 | 800 | 985 |
Total Liabilities and Equity |
| 756 | 775 | 1,028 | 1,043 | 1,204 |
Cash per Share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
Cash, Current Inv Per share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |